The investigational once-weekly dual GLP-1/GIP receptor agonist, engineered with signaling bias at both receptors, met both primary end points at 48 weeks.
|Articles|August 4, 2021
Pharmacy Clinical Pearl of the Day: Long-Term Metformin Use and Vitamin B12 Deficiency
Author(s)Saro Arakelians, PharmD
Patients on metformin should check their vitamin B12 levels on regular basis to make sure it is at normal range.
Advertisement
Clinical Pearl of the Day:
Long term use of metformin can cause vitamin B12 deficiency.
Explanation:
- The mechanism by which metformin reduces the vitamin B12 levels is still unknown, but the most likely hypothesis is that metformin interferes with the calcium-dependent membrane action responsible for vitamin B12 intrinsic factor absorption, which occurs in the terminal ileum.
- Patients on metformin should check their B12 levels on regular basis, possibly annually, to make sure it is within a normal range.
- The normal level of vitamin B12 in the bloodstream is generally between 190 and 950 picograms per milliliter (pg/ml)
Advertisement
Related to this article
HYPERION trial data now support sotatercept within a patient's first year of pulmonary arterial hypertension (PAH) diagnosis, cutting clinical worsening risk by 76% compared with placebo.
A stewardship program combining EHR alerts and pharmacist-led education offers a replicable model for reducing bleeding risk.
Tim Cernohous of Cencora explains why patient trust no longer guarantees satisfaction—and how automation and better communication can close the gap with mail order.
Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
At NEIAP 2026, Kelsey Norman, PharmD, walked through how VESALIUS-CV, Lp(a)HORIZON, and CKM guidelines change pharmacist-led lipid care.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bridging the Gap: Pharmacist Experiences Obtaining DEA Licenses
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Comparison of Weight-Based vs Non–Weight-Based Norepinephrine Dosing in Patients With Septic Shock
5